Cargando…

Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease

PURPOSE: Transsphenoidal surgery (TSS) is the primary treatment modality for Cushing’s disease (CD). However, the predictors of post-operative remission and recurrence remain debatable. Thus, we studied the post-operative remission and long-term recurrence rates, as well as their respective predicti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Prachi, Lila, Anurag, Goroshi, Manjunath, Jadhav, Swati, Lomte, Nilesh, Thakkar, Kunal, Goel, Atul, Shah, Abhidha, Sankhe, Shilpa, Goel, Naina, Jaguste, Neelam, Bandgar, Tushar, Shah, Nalini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640573/
https://www.ncbi.nlm.nih.gov/pubmed/28912338
http://dx.doi.org/10.1530/EC-17-0175
_version_ 1783271050998448128
author Bansal, Prachi
Lila, Anurag
Goroshi, Manjunath
Jadhav, Swati
Lomte, Nilesh
Thakkar, Kunal
Goel, Atul
Shah, Abhidha
Sankhe, Shilpa
Goel, Naina
Jaguste, Neelam
Bandgar, Tushar
Shah, Nalini
author_facet Bansal, Prachi
Lila, Anurag
Goroshi, Manjunath
Jadhav, Swati
Lomte, Nilesh
Thakkar, Kunal
Goel, Atul
Shah, Abhidha
Sankhe, Shilpa
Goel, Naina
Jaguste, Neelam
Bandgar, Tushar
Shah, Nalini
author_sort Bansal, Prachi
collection PubMed
description PURPOSE: Transsphenoidal surgery (TSS) is the primary treatment modality for Cushing’s disease (CD). However, the predictors of post-operative remission and recurrence remain debatable. Thus, we studied the post-operative remission and long-term recurrence rates, as well as their respective predictive factors. METHODS: A retrospective analysis of case records of 230 CD patients who underwent primary microscopic TSS at our tertiary care referral centre between 1987 and 2015 was undertaken. Demographic features, pre- and post-operative hormonal values, MRI findings, histopathological features and follow-up data were recorded. Remission and recurrence rates as well as their respective predictive factors were studied. RESULTS: Overall, the post-operative remission rate was 65.6% (early remission 46%; delayed remission 19.6%), while the recurrence rate was 41% at mean follow-up of 74 ± 61.1 months (12–270 months). Significantly higher early remission rates were observed in patients with microadenoma vs macroadenoma (51.7% vs 30.6%, P = 0.005) and those with unequivocal vs equivocal MRI for microadenoma (55.8% vs 38.5%, P = 0.007). Patients with invasive macroadenoma had poorer (4.5% vs 45%, P = 0.001) remission rates. Recurrence rates were higher in patients with delayed remission than those with early remission (61.5% vs 30.8%, P = 0.001). Duration of post-operative hypocortisolemia ≥13 months predicted sustained remission with 100% specificity and 46.4% sensitivity. Recurrence could be detected significantly earlier (27.7 vs 69.2 months, P < 0.001) in patients with available serial follow-up biochemistry as compared to those with infrequent follow-up after remission. CONCLUSION: In our study, remission and recurrence rates were similar to that of reported literature, but proportion of delayed remission was relatively higher. Negative/equivocal MRI findings and presence of macroadenoma, especially those with cavernous sinus invasion were predictors of poor remission rates. In addition to early remission, longer duration of post-operative hypocortisolism is an important predictor of sustained remission. Regular biochemical surveillance may help in identifying recurrence early.
format Online
Article
Text
id pubmed-5640573
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-56405732017-10-23 Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease Bansal, Prachi Lila, Anurag Goroshi, Manjunath Jadhav, Swati Lomte, Nilesh Thakkar, Kunal Goel, Atul Shah, Abhidha Sankhe, Shilpa Goel, Naina Jaguste, Neelam Bandgar, Tushar Shah, Nalini Endocr Connect Research PURPOSE: Transsphenoidal surgery (TSS) is the primary treatment modality for Cushing’s disease (CD). However, the predictors of post-operative remission and recurrence remain debatable. Thus, we studied the post-operative remission and long-term recurrence rates, as well as their respective predictive factors. METHODS: A retrospective analysis of case records of 230 CD patients who underwent primary microscopic TSS at our tertiary care referral centre between 1987 and 2015 was undertaken. Demographic features, pre- and post-operative hormonal values, MRI findings, histopathological features and follow-up data were recorded. Remission and recurrence rates as well as their respective predictive factors were studied. RESULTS: Overall, the post-operative remission rate was 65.6% (early remission 46%; delayed remission 19.6%), while the recurrence rate was 41% at mean follow-up of 74 ± 61.1 months (12–270 months). Significantly higher early remission rates were observed in patients with microadenoma vs macroadenoma (51.7% vs 30.6%, P = 0.005) and those with unequivocal vs equivocal MRI for microadenoma (55.8% vs 38.5%, P = 0.007). Patients with invasive macroadenoma had poorer (4.5% vs 45%, P = 0.001) remission rates. Recurrence rates were higher in patients with delayed remission than those with early remission (61.5% vs 30.8%, P = 0.001). Duration of post-operative hypocortisolemia ≥13 months predicted sustained remission with 100% specificity and 46.4% sensitivity. Recurrence could be detected significantly earlier (27.7 vs 69.2 months, P < 0.001) in patients with available serial follow-up biochemistry as compared to those with infrequent follow-up after remission. CONCLUSION: In our study, remission and recurrence rates were similar to that of reported literature, but proportion of delayed remission was relatively higher. Negative/equivocal MRI findings and presence of macroadenoma, especially those with cavernous sinus invasion were predictors of poor remission rates. In addition to early remission, longer duration of post-operative hypocortisolism is an important predictor of sustained remission. Regular biochemical surveillance may help in identifying recurrence early. Bioscientifica Ltd 2017-09-14 /pmc/articles/PMC5640573/ /pubmed/28912338 http://dx.doi.org/10.1530/EC-17-0175 Text en © 2017 The authors http://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Research
Bansal, Prachi
Lila, Anurag
Goroshi, Manjunath
Jadhav, Swati
Lomte, Nilesh
Thakkar, Kunal
Goel, Atul
Shah, Abhidha
Sankhe, Shilpa
Goel, Naina
Jaguste, Neelam
Bandgar, Tushar
Shah, Nalini
Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease
title Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease
title_full Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease
title_fullStr Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease
title_full_unstemmed Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease
title_short Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease
title_sort duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for cushing’s disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640573/
https://www.ncbi.nlm.nih.gov/pubmed/28912338
http://dx.doi.org/10.1530/EC-17-0175
work_keys_str_mv AT bansalprachi durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease
AT lilaanurag durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease
AT goroshimanjunath durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease
AT jadhavswati durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease
AT lomtenilesh durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease
AT thakkarkunal durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease
AT goelatul durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease
AT shahabhidha durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease
AT sankheshilpa durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease
AT goelnaina durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease
AT jagusteneelam durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease
AT bandgartushar durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease
AT shahnalini durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease